Evidence map›Paper›PMID 28622331›Full record

ArticlePLoS computational biology2017

In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis.

Michael A Colman, Haibo Ni, Bo Liang, Nicole Schmitt, Henggui Zhang

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. ArrhythmoGenoPharmacoTherapy.Frontiers in pharmacology · 2020
    Review
  11. Ultrarapid Delayed Rectifier KFrontiers in cell and developmental biology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Genetics of atrial fibrillation: an update.Current opinion in cardiology · 2018
    Review
  16. Frontiers in physiology · 2018
    Article
  17. Article
  18. Article
  19. Frontiers in pharmacology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Michael A ColmanBiological Physics Group, School of Physics and Astronomy, University of Manchester, Manchester, United Kingdom.ORCID http://orcid.org/0000-0003-2817-8508
Haibo NiBiological Physics Group, School of Physics and Astronomy, University of Manchester, Manchester, United Kingdom.ORCID http://orcid.org/0000-0003-0083-4286
Bo LiangDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nicole SchmittDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-9482-9749
Henggui ZhangBiological Physics Group, School of Physics and Astronomy, University of Manchester, Manchester, United Kingdom.ORCID http://orcid.org/0000-0002-0863-5807
University of Copenhagen · DKHarbin Institute of Technology · CNUniversity of Leeds · GBUniversity of Manchester · GB

Funding

British Heart Foundation FS/14/5/30533Medical Research Council MR/M014967/1
6 · The paper itself

Abstract

A recent experimental study investigating patients with lone atrial fibrillation identified six novel mutations in the KCNA5 gene. The mutants exhibited both gain- and loss-of-function of the atrial specific ultra-rapid delayed rectifier K+ current, IKur. The aim of this study is to elucidate and quantify the functional impact of these KCNA5 mutations on atrial electrical activity. A multi-scale model of the human atria was updated to incorporate detailed experimental data on IKur from both wild-type and mutants. The effects of the mutations on human atrial action potential and rate dependence were investigated at the cellular level. In tissue, we assessed the effects of the mutations on the vulnerability to unidirectional conduction patterns and dynamics of re-entrant excitation waves. Gain-of-function mutations shortened the action potential duration in single cells, and stabilised and accelerated re-entrant excitation in tissue. Loss-of-function mutations had heterogeneous effects on action potential duration and promoted early-after-depolarisations following beta-adrenergic stimulation. In the tissue model, loss-of-function mutations facilitated breakdown of excitation waves at more physiological excitation rates than the wild-type, and the generation of early-after-depolarisations promoted unidirectional patterns of excitation. Gain- and loss-of-function IKur mutations produced multiple mechanisms of atrial arrhythmogenesis, with significant differences between the two groups of mutations. This study provides new insights into understanding the mechanisms by which mutant IKur contributes to atrial arrhythmias. In addition, as IKur is an atrial-specific channel and a number of IKur-selective blockers have been developed as anti-AF agents, this study also helps to understand some contradictory results on both pro- and anti-arrhythmic effects of blocking IKur.

Indexed as

Models, CardiovascularModels, GeneticAtrial FibrillationComputer SimulationGenetic VariationHeart Conduction SystemHumansIon Channel GatingKv1.5 Potassium ChannelMutationPolymorphism, Single NucleotideSignal TransductionStructure-Activity RelationshipKCNA5 protein, humanKv1.5 Potassium Channel

Identifiers

PMID28622331
PMCPMC5493429
OpenAlexW2625476692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.